Quay Pharmaceuticals is experienced in providing a comprehensive out-sourcing service for formulation and analytical development with subsequent clinical trials and commercial manufacturing for pharmaceutical and biotechnology companies world-wide.
Working as a dedicated, pro-active part of your team we apply strong project management and technical expertise to take products quickly and cost effectively from late stage preclinical through to the end of phase III clinical trials and commercial manufacturing.
Quay Pharma has vast expertise in dosage form design and development. We have built a reputation for specialising in the formulation of API's that exhibit poor solubility and bio-availability and those which require modified or controlled release. Including Live Bio Therapeutics. Quay Pharma holds a Manufacturing Authorisation from the MHRA and was successfully FDA inspected.
« Go Back